Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.
Despite its unparalleled merits for prostate cancer detection and staging, prostate-specific antigen (PSA) is not a marker for prostate cancer only, but also is expressed in benign conditions. For early detection, limitations of PSA are obvious. Its widespread use has led to an extensive amount of e...
Main Authors: | Haese, A, Graefen, M, Huland, H, Lilja, H |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2004
|
Registos relacionados
-
[Isoforms of free prostate-specific antigen]
Por: Haese, A, et al.
Publicado em: (2004) -
Isoforms of free prostate-specific antigen
Por: Haese, A, et al.
Publicado em: (2004) -
Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.
Por: Steuber, T, et al.
Publicado em: (2002) -
Total and gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies
Por: Haese, A, et al.
Publicado em: (2003) -
Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.
Por: Haese, A, et al.
Publicado em: (2003)